Is there a generic for Potassium acetate?

Yes. The FDA Orange Book lists 3 approved generic (ANDA) applications for Potassium acetate, referencing the brand POTASSIUM ACETATE. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Potassium acetate?

POTASSIUM ACETATE (NDA 018896, HOSPIRA) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Potassium acetate are approved?

Potassium acetate is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Potassium acetate

Potassium acetate is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:POTASSIUM ACETATE · NDA 018896

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
POTASSIUM ACETATERLD	HOSPIRA	NDA 018896	AP	Jul 20, 1984

Generic (ANDA) products (3)

Product	Applicant	Application	TE	Approved
POTASSIUM ACETATE	FRESENIUS KABI USA	ANDA 217515	AP	Nov 27, 2024
POTASSIUM ACETATE	EXELA PHARMA	ANDA 212692	AP	Oct 20, 2021
POTASSIUM ACETATE	EXELA PHARMA	ANDA 206203	—	Dec 29, 2015

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Potassium acetate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo